Why the study?
The impact of modern dissection and reentry techniques on the long-term outcomes of CTO PCI remains controversial.
Does extraplaque tracking compared to intraplaque tracking affect clinical outcomes in patients undergoing chronic total occlusion percutaneous coronary intervention?
Does extraplaque tracking compared to intraplaque tracking affect clinical outcomes in patients undergoing chronic total occlusion percutaneous coronary intervention?
Extraplaque tracking in CTO PCI is associated with a higher risk of MACE and TVR at 1 year compared to intraplaque tracking, likely driven by greater baseline lesion complexity.
Answers are grounded in this paper and cite their sources.
May warrant preferring IP tracking in CTO PCI when feasible; leaves open whether RCTs will confirm these observational associations.
OBJECTIVE: To compare the clinical outcomes after extraplaque (EP) versus intraplaque (IP) tracking in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). BACKGROUND: The impact of modern dissection and reentry (DR) techniques on the long-term outcomes of CTO PCI remains controversial. METHODS: We performed a systematic review and meta-analysis of studies that compared EP versus IP tracking in CTO PCI. Odds ratios (ORs) with 95% confidence intervals (CIs) are calculated using the Der-Simonian and Laird random-effects method. RESULTS: Our meta-analysis included seven observational studies with 2982 patients. Patients who underwent EP tracking had significantly more complex CTOs with higher J-CTO score, longer lesion length, and more severe calcification and had significantly longer stented segments. During a median follow-up of 12 months (range 9-12 months), EP tracking was associated with a higher risk of major adverse cardiovascular events (MACE) (OR 1.50, 95% CI (1.10-2.06), p = 0.01) and target vessel revascularization (TVR) (OR 1.69, 95% CI (1.15-2.48), p = 0.01) compared with IP tracking. There was no difference in the incidence of all-cause death (OR 1.37, 95% CI (0.67-2.78), p = 0.39), myocardial infarction (MI) (OR 1.48, 95% CI (0.82-2.69), p = 0.20), stent thrombosis (OR 2.09, 95% CI (0.69-6.33), p = 0.19), or cardiac death (OR 1.10, 95% CI (0.39-3.15), p = 0.85) between IP and EP tracking. CONCLUSION: EP tracking is utilized in more complex CTOs and requires more stents. EP tracking is associated with a higher risk of MACE, driven by a higher risk of TVR at 1 year, but without an increased risk of death or MI compared with IP tracking. EP tracking is critically important for contemporary CTO PCI.
No takes yet. Share an insight, caveat, or question.
Megaly et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: